On Friday, Vir Biotechnology Inc (NASDAQ: VIR) opened higher 3.18% from the last session, before settling in for the closing price of $7.86. Price fluctuations for VIR have ranged from $7.41 to $13.09 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 421.39%. Company’s average yearly earnings per share was noted 26.24% at the time writing. With a float of $88.17 million, this company’s outstanding shares have now reached $134.78 million.
Let’s determine the extent of company efficiency that accounts for 587 employees. In terms of profitability, gross margin is 80.31%, operating margin of -673.27%, and the pretax margin is -682.39%.
Vir Biotechnology Inc (VIR) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Vir Biotechnology Inc is 35.49%, while institutional ownership is 51.03%. The most recent insider transaction that took place on Sep 09 ’24, was worth 95,032. In this transaction Director of this company sold 12,190 shares at a rate of $7.80, taking the stock ownership to the 11,616 shares. Before that another transaction happened on Sep 09 ’24, when Company’s Director proposed sale 12,190 for $7.76, making the entire transaction worth $94,594.
Vir Biotechnology Inc (VIR) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.89 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.00% during the next five years compared to -34.12% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Check out the current performance indicators for Vir Biotechnology Inc (VIR). In the past quarter, the stock posted a quick ratio of 12.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 14.05.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.58, a number that is poised to hit -1.05 in the next quarter and is forecasted to reach -3.77 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Looking closely at Vir Biotechnology Inc (NASDAQ: VIR), its last 5-days average volume was 0.79 million, which is a drop from its year-to-date volume of 1.02 million. As of the previous 9 days, the stock’s Stochastic %D was 51.35%. Additionally, its Average True Range was 0.36.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 12.32%, which indicates a significant decrease from 48.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.84% in the past 14 days, which was lower than the 62.92% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.90, while its 200-day Moving Average is $9.61. However, in the short run, Vir Biotechnology Inc’s stock first resistance to watch stands at $8.21. Second resistance stands at $8.30. The third major resistance level sits at $8.45. If the price goes on to break the first support level at $7.97, it is likely to go to the next support level at $7.82. Should the price break the second support level, the third support level stands at $7.73.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
There are currently 136,059K shares outstanding in the company with a market cap of 1.11 billion. Presently, the company’s annual sales total 86,180 K according to its annual income of -615,060 K. Last quarter, the company’s sales amounted to 3,080 K and its income totaled -138,380 K.
